1. Introduction – Batch Packing Record for Clobetasol Propionate, Neomycin Sulphate & Miconazole Nitrate Cream:
The Batch Packing Record (BPR) for Clobetasol Propionate, Neomycin Sulphate & Miconazole Nitrate Cream provides documented instructions and controls for the filling, sealing, coding, packing, inspection, reconciliation, and release of the finished pharmaceutical product. The formulation contains Clobetasol Propionate IP 0.05% w/w, Neomycin Sulphate IP 0.50% w/w, and Miconazole Nitrate IP 2.00% w/w in a cream base. The product is required to be stored at a temperature not exceeding 25°C and should not be frozen. This procedure is designed to ensure that the cream is packed consistently under controlled conditions while maintaining product quality, identity, safety, and traceability. Before starting packing activities, appropriate line clearance, area and machine cleaning, verification of packaging materials, and removal of materials from the previous product or batch are required. During tube filling, the BPR provides for routine in-process monitoring of tube cleaning, empty tube inspection, filling and sealing, filled-tube inspection, target weight, filling range, cap sealing, and rejection recording. The documented target weight is 10.3 g, with a filling range of 10.0–10.9 g, checked at a frequency of 60 minutes.Proper execution of this BPR helps prevent mix-ups, packing errors, incorrect coding, under- or over-filling, and reconciliation discrepancies while providing complete documentation for production and Quality Assurance review.
Skip to PDF content2. Flow Diagram for Filling, Sealing and Packing of Clobetasol Propionate, Neomycin Sulphate & Miconazole Nitrate Cream:
The flow diagram describes the controlled sequence followed during the filling, sealing, coding, packing, reconciliation, and release of Clobetasol Propionate, Neomycin Sulphate & Miconazole Nitrate Cream. The process begins with line clearance and area preparation, ensuring removal of previous product, packing materials, labels, and residues before commencement of the batch. Required packaging components such as laminated tubes, inner cartons, multicartons, shippers, and BOPP tape are then dispensed according to the Batch Packing Record.
The filling and sealing machine is prepared, cleaned, and verified before use. Cream is filled into tubes, sealed, and subjected to in-process checks. These checks include tube cleaning, empty-tube inspection, filled-tube inspection, weight verification, cap sealing, and rejection recording. The documented target weight is 10.3 g, with an acceptable filling range of 10.0–10.9 g, checked at a frequency of 60 minutes. After satisfactory quality checks, batch details such as batch number, manufacturing date, expiry date, and MRP are verified during coding and overprinting. Tubes are packed into inner cartons, multicartons, and shippers. Finally, packing materials and finished packs are reconciled, deviations are documented, required samples are collected, and the completed batch is reviewed for final release by Production and Quality Assurance.
3. Critical Process Parameters (CPP) and Critical Quality Attributes (CQA):
The Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) for Clobetasol Propionate, Neomycin Sulphate & Miconazole Nitrate Cream are essential for maintaining consistent filling, sealing, packing, and finished-product quality. Key CPPs include proper line clearance, correct dispensing of packaging materials, machine setup, tube cleaning, filling control, sealing, coding, and packing operations. The Batch Packing Record specifies a target fill weight of 10.3 g with an acceptable filling range of 10.0–10.9 g, with in-process checks performed at a frequency of 60 minutes.
Other important process controls include verification of the correct laminated tube, inner carton, multicarton, shipper, and BOPP tape, along with removal of previous-product materials and proper line clearance before operation. The major CQAs include correct product identity, fill quantity, proper tube sealing, legible coding, correct batch details, packaging integrity, and acceptable finished-pack presentation. The formulation contains Clobetasol Propionate IP 0.05% w/w, Neomycin Sulphate IP 0.50% w/w, and Miconazole Nitrate IP 2.00% w/w. The packed product should be stored at not more than 25°C and should not be frozen.